CAS number：1414386-05-2 molecular formula：
Sonelokimab (ALX 0761; M 1095) is a trivalent nanobody comprised of monovalent camelid-derived nanobodies specific to human interleukin (IL)-17A, IL-17F , and human serum albumin VHHs. Sonelokimab has the potential for plaque-type psoriasis research IC50& Target:IL-17A|IL-17F
| Chinese alias | 索奈洛昔单抗 | ||
| English alias | - | ||
| CAS number | 1414386-05-2 | molecular formula | |
| molecular weight | - | Exact mass | - |
| PSA | - | logp | - |
No numbering system information yet
No physical and chemical property information yet
No safety information yet
No production method and use information yet
No upstream information yet
No downstream information yet
